Tamara A. Bazhenova , Gennadiy V. Shilov , Denis V. Korchagin , Galina S. Tsebrikova , Yulia R. Aleksandrova , Dmitry V. Baulin , Natalya S. Nikolaeva , Mariya A. Lapshina , Margarita E. Neganova , Vladimir E. Baulin
{"title":"Synthesis, crystal structures and cytotoxic activity of new Cu(II) complexes based on podands with terminal 8-oxyquinolyl groups","authors":"Tamara A. Bazhenova , Gennadiy V. Shilov , Denis V. Korchagin , Galina S. Tsebrikova , Yulia R. Aleksandrova , Dmitry V. Baulin , Natalya S. Nikolaeva , Mariya A. Lapshina , Margarita E. Neganova , Vladimir E. Baulin","doi":"10.1016/j.poly.2025.117607","DOIUrl":null,"url":null,"abstract":"<div><div>In this study, we present the synthesis of four novel Cu(II) complexes based on podands with terminal 8-oxyquinolyl groups and evaluation of their potential anticancer activity. The syntheses of ligands were achieved by a unified procedure in which 1,5-bis(8-oxyquinolyl)-3-oxapentane (L<sup>1</sup>), 2,6-bis((8-oxyquinolyl)methyl)pyridine (L<sup>2</sup>), 1,8-bis(8-oxyquinolyl)-3,6-dioxaoctane (L<sup>3</sup>) were prepared by a one-step reaction of 2 equiv. of 8-hydroxyquinoline sodium salt with diethylene glycol ditosyl, 2,6-bis(tosylatemethyl)pyridine and triethylene glycol ditosyl, respectively, in good yields. The synthesis of copper(II) complexes [Cu<sub>2</sub>L<sup>1</sup>Br<sub>2</sub>(<em>µ</em>-OCH<sub>3</sub>)<sub>2</sub>] (<strong>1</strong>), [Cu<sub>2</sub>L<sup>1</sup>Br<sub>2</sub>(<em>µ</em>-OH)(<em>µ</em>-Br)] (<strong>2</strong>), [Cu<sub>2</sub>L<sup>1</sup>Br<sub>2</sub>(<em>µ</em>-Br)<sub>2</sub>]·CH<sub>3</sub>CN (<strong>3</strong>), and [CuL<sup>2</sup>Br]Br (<strong>4</strong>) was performed through the reaction of CuBr<sub>2</sub> with L<sup>1</sup> and L<sup>2</sup> ligands under mild conditions. Single crystal X-ray diffraction analysis revealed that complexes <strong>1–3</strong> possessed binuclear structures, while complex <strong>4</strong> exhibited a mononuclear configuration. The <em>in vitro</em> anticancer activities of the four complexes were evaluated against four different cancer cell lines. The complexes exhibited higher activity compared to their respective free ligands, inducing cell growth inhibition and apoptosis in a concentration-dependent manner. Compounds <strong>3</strong> and <strong>4</strong> exhibited the most pronounced cytotoxic effect against the A549 cell line, with IC<sub>50</sub> values of 21.43 ± 0.20 and 30.67 ± 2.23 μM, respectively. It is also noteworthy that lower IC<sub>50</sub> values were observed for all compounds against Hek-293 cells of normal origin. A selectivity index of 2 was calculated for compound <strong>3</strong>. According to study of the effect on apoptosis, compounds <strong>1</strong> and <strong>4</strong> at the selected concentration after 24 h significantly increased the percentage of the apoptotic population. Confocal microscopy revealed that all the synthesized complexes penetrate into the cells and localize in the perinuclear space. It is suggested that aberrant glycolysis is one of the primary targets of the action of Cu(II) complexes <strong>1</strong>–<strong>4</strong>, and the detected cytotoxic activity appears to be related to the ability of <strong>1</strong>–<strong>4</strong> to alter the pathological mechanism of tumor cell metabolism.</div></div>","PeriodicalId":20278,"journal":{"name":"Polyhedron","volume":"278 ","pages":"Article 117607"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polyhedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277538725002219","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0
Abstract
In this study, we present the synthesis of four novel Cu(II) complexes based on podands with terminal 8-oxyquinolyl groups and evaluation of their potential anticancer activity. The syntheses of ligands were achieved by a unified procedure in which 1,5-bis(8-oxyquinolyl)-3-oxapentane (L1), 2,6-bis((8-oxyquinolyl)methyl)pyridine (L2), 1,8-bis(8-oxyquinolyl)-3,6-dioxaoctane (L3) were prepared by a one-step reaction of 2 equiv. of 8-hydroxyquinoline sodium salt with diethylene glycol ditosyl, 2,6-bis(tosylatemethyl)pyridine and triethylene glycol ditosyl, respectively, in good yields. The synthesis of copper(II) complexes [Cu2L1Br2(µ-OCH3)2] (1), [Cu2L1Br2(µ-OH)(µ-Br)] (2), [Cu2L1Br2(µ-Br)2]·CH3CN (3), and [CuL2Br]Br (4) was performed through the reaction of CuBr2 with L1 and L2 ligands under mild conditions. Single crystal X-ray diffraction analysis revealed that complexes 1–3 possessed binuclear structures, while complex 4 exhibited a mononuclear configuration. The in vitro anticancer activities of the four complexes were evaluated against four different cancer cell lines. The complexes exhibited higher activity compared to their respective free ligands, inducing cell growth inhibition and apoptosis in a concentration-dependent manner. Compounds 3 and 4 exhibited the most pronounced cytotoxic effect against the A549 cell line, with IC50 values of 21.43 ± 0.20 and 30.67 ± 2.23 μM, respectively. It is also noteworthy that lower IC50 values were observed for all compounds against Hek-293 cells of normal origin. A selectivity index of 2 was calculated for compound 3. According to study of the effect on apoptosis, compounds 1 and 4 at the selected concentration after 24 h significantly increased the percentage of the apoptotic population. Confocal microscopy revealed that all the synthesized complexes penetrate into the cells and localize in the perinuclear space. It is suggested that aberrant glycolysis is one of the primary targets of the action of Cu(II) complexes 1–4, and the detected cytotoxic activity appears to be related to the ability of 1–4 to alter the pathological mechanism of tumor cell metabolism.
期刊介绍:
Polyhedron publishes original, fundamental, experimental and theoretical work of the highest quality in all the major areas of inorganic chemistry. This includes synthetic chemistry, coordination chemistry, organometallic chemistry, bioinorganic chemistry, and solid-state and materials chemistry.
Papers should be significant pieces of work, and all new compounds must be appropriately characterized. The inclusion of single-crystal X-ray structural data is strongly encouraged, but papers reporting only the X-ray structure determination of a single compound will usually not be considered. Papers on solid-state or materials chemistry will be expected to have a significant molecular chemistry component (such as the synthesis and characterization of the molecular precursors and/or a systematic study of the use of different precursors or reaction conditions) or demonstrate a cutting-edge application (for example inorganic materials for energy applications). Papers dealing only with stability constants are not considered.